Program Title
8:30 – 9:00
Registration and Breakfast
9:00 – 9:10
Welcome and Introduction
Bradly Wouters, PhD, Executive Vice President of Science and Research, University Health Network
Keith Stewart, MD, Vice President, Cancer, and Director of the Princess Margaret Cancer Centre, University Health Network
Session Chair: Dr. Erica Tsang, MD, Princess Margaret Cancer Centre, Toronto, ON
9:10 – 9:50
KEYNOTE: Pancreatic cancer – exceptional survivors to RNA vaccines
Speaker: Vinod Balachandran, MD, Memorial Sloan Kettering Cancer Center, New York, NY
9:50 – 10:20
Title: Deciphering the determinants of hematopoietic clonal outgrowth using single-cell multi-omics
Speaker: Federico Gaiti, PhD, Princess Margaret Cancer Centre, Toronto, ON
10:20 – 10:50
Title: Genomic and epigenomic evolution in serial ctDNA from metastatic prostate cancer
Speaker: Alexander Wyatt, PhD, Vancouver Prostate Centre, BC Cancer, Vancouver, BC
10:50 – 11:05
Panel Discussion
All morning session speakers
11:05 – 11:20
Debate Moderator: Dr. Haeseong Park, MD, PhD, Dana-Farber Cancer Institute, Boston, MA
11:20 – 11:40
Debate: FOR – Cancer interception in molecular residual disease will improve survival in many solid tumors
Speaker: Anna Spreafico, MD, PhD, Princess Margaret Cancer Centre, Toronto, ON
11:40 – 12:00
Speaker: George Zogopoulos, MD, PhD, McGill University, Montreal, QC
12:00 - 12:05
Debate: FOR (rebuttal)
12:05 - 12:10
Debate: AGAINST(rebuttal)
12:10 - 1:00
Session Chair: Dr. Abi Vijenthira, MD, Princess Margaret Cancer Centre, Toronto, ON
1:00 – 1:50
KEYNOTE: Updates on Cellular Therapy, Lessons Learned from Large B-cell Lymphoma
Speaker: Loretta Nastoupil, MD, MD Anderson Cancer Center, Houston, TX
1:50 – 2:20
Title: Unraveling Single-Cell Spatial Landscapes of Lung and Brain Tumor Immune Microenvironments using Artificial Intelligence
Speaker: Logan Walsh, PhD, McGill University, Montreal, QC
2:20 – 2:35
Session Chair: Dr. Pamela Ohashi, PhD, Princess Margaret Cancer Centre, Toronto, ON
2:35 - 3:05
Title: Chronic Interferon, Inflammatory Memory, and Cancer Immunotherapy Resistance
Speaker: Andy Minn, MD, PhD, University of Pennsylvania, PA
3:05 – 3:20
Panel Discussion
All afternoon session speakers
3:20 – 3:25
Closing Remarks